A AB BS ST TR RA AC CT T O Ob bj je ec ct ti iv ve e: : Nosocomial bloodstream infections are serious health problems in hospitals all over the world. They are associated with a high rate of morbidity and mortality, prolonged hospital stay and higher costs. The aim of this study was to evaluate the clinical outcomes of the patients with gram-negative bacteremia and to identify the risk factors for mortality. M Ma at te er ri ia al l a an nd d M Me et th ho od ds s: : A prospective observational study was performed in the 1196-bed Ankara Numune Education and Research Hospital. The patients with nosocomial gram-negative bacteremia were included in the study from July 2006 to June 2008. Bacteremia was considered to be nosocomial when it was diagnosed at least 48 h after hospital admission. Gram-negative bacteremia was defined as the presence of gram-negative bacteria in the blood, documented by at least 1 positive hemoculture. In patients who had more than one episode of gram-negative bacteremia, only the first episode was considered. Antibiotic therapy was considered to be appropriate if the drugs used had in vitro activity against the isolated strain. R Re es su ul lt ts s: : Among the 253 cases (mean age: 54.5± 20 years old, male/female: 159/94) of Gram-negative bacteremia included in the study, the most frequently detected microorganisms were Escherichia coli (n=96, 37.9%), Acinetobacter spp. (n=54, 21.33%), Pseudomonas aeruginosa (n=41, 16.2%), Klebsiella spp. (n=39, 15.4%), Enterobacter spp. (n=9, 3.5%) and Stenotrophomonas maltophilia (n=6, 2.3%). The mean duration of hospital stay until Gram-negative bacteremia was 19 ±17 (range 3-82) days. Mortality rates at 14 days and at 30 days after the bacteremia were, respectively, 28.5% and 38.4%. We found that Acute Physiology and Chronic Health Evaluation (APACHE) II score over 20, inappropriate antibiotic treatment, receiving total parenteral nutrition, unconsciousness and thrombocytopenia were significant independent risk factors for mortality at day 30 after the Gramnegative bacteremia. C Co on nc cl lu us si io on n: : Awareness of mortality risk factors is important for the prognosis. Appropriate antibiotic treatment could decrease deaths associated with Gram-negative bacteremia. 
osocomial bloodstream infections (BSI) are serious health problem in hospitals all over the world, associated with high rate of morbidity and mortality, prolonged hospital stay and higher costs. 1, 2 Gram-negative bacteria are responsible for a considerable percentage of all bloodstream infections in approximately 50% of nosocomial BSIs. 3 The most common Gram-negative bacteria isolated in nosocomial BSIs are Pseudomonas aeruginosa, Acinetobacter species, Klebsiella pneumoniae, and Enterobacter species. 4, 5 Gram-negative bacteremia is a serious infection related with significant morbidity and mortality. 6 Mortality is usually associated with shock, multi-organ failure, severity of underlying disease, and appropriateness of antibiotic therapy. [7] [8] [9] This study was planned to evaluate the clinical outcomes of the patients with Gram-negative bacteremia and to identify the risk factors for mortality.
MATERIAL AND METHODS
A prospective observational study design was employed with the main outcome measures 14-and 30-days in-hospital mortality. This study was conducted at a 1,196 bed teaching hospital, Ankara Numune Education and Research Hospital, in Turkey. The hospital contains all major departments except pediatric department, including medical and surgical sub-specialties, medical and surgical Intensive Care Units (ICUs). During a 2-year period (1 July 2006 to 30 June 2008), all hospitalized patients with a positive blood culture for Gram-negative bacteria were included if they were ≥16 years old, the blood culture met the Centers for Disease Control and Prevention criteria for infection and infection occurred ≥48 hours after hospital admission. Gram-negative bacteremia was defined as at least 1 positive hemoculture for Gramnegative bacteria. In patients who had more than one episode of Gram-negative bacteremia, only the first episode was considered. Patients with polymicrobial bacteremia were excluded. Primary bacteremia was defined as a confirmed BSI without any recognizable primary site of infection. The diagnosis of bacteremia was based on the criteria of the Centers for Disease Control and Prevention. 10, 11 E.coli and Klebsiella spp. strains were defined as multi-drug resistant (MDR) if resistance was observed to at least 3 out of 5 classes of antimicrobial agents, ie, ampicillin-sulbactam, piperacillin tazobactam, cephalosporins, quinolones, aminoglycosides.
In Pseudomonas spp. ve Acinetobacter spp. strains, imipenem resistance were explored.
If a patient received at least one antimicrobial agent at the day of blood culture collection to which the causative microorganisms were susceptible, empirical antimicrobial therapy was considered to have been appropriate. Inappropriate empirical antibiotic treatment was switched to an appropriate regimen according to antimicrobial susceptibility result. If a patient did not receive any antimicrobial agent overall to which the causative microorganisms were susceptible, antimicrobial therapy was considered to have been inappropriate.
Blood culture positivity was established with BacT/Alert (BioMerieux, Dunham, NC) automated blood culture system. Identification and antimicrobial susceptibility of the Gram-negative bacteria were performed by VITEK 2 automated system (BioMerieux, France). GN panel was used for the identification, and GN 528 panel was used for the detection of antimicrobial susceptibility.
The following data were obtained for each patient from the medical records and a computer database: Demographics, primary diagnosis, surgery, hospitalization period before Gram Potential risk factors for all-cause 14-and 30-day mortality among all patients were assessed. A p-value of <0.05 was considered statistically significant. The Chi-square test or Fisher's exact test was used, when appropriate to compare proportions. Continuous variables were compared using an independent-groups Student's t test. Survival curves with a 95% confidence interval were computed using the Kaplan-Meier method. Cox regression was used to model 30-day in hospital mortality. The starting time point was the Gram-negative bacteria positive blood culture collection and the ending time point was either death or 30 th day. For multivariate analysis, only variables with a p value <0.05 were entered into a Cox proportional hazards model and selected using a backward stepwise selection procedure. Hazard ratios (HR) and 95% confidence intervals (95% CI) were computed from estimated parameters of the final regression model. Software package Stata 11.0 (College station, Texas, USA) was used for the analysis.
The study protocol was approved by the Local Ethics Committee of Ankara Numune Education and Research Hospital.
RESULTS
Among the 253 cases (mean age: 54.5±20 years, male/female: 159/94) of Gram-negative bacteremia included in the study, the most frequently detected microorganisms were E. coli (n=96, 37.9%), Acinetobacter spp. (n=54, 21.33%), P. aeruginosa (n=41, 16.2%), Klebsiella spp. (n=39, 15.4%), Enterobacter spp. (n=9, 3.5%) and S. maltophilia (n=6, 2.3%) ( Table 1 ). The mean duration of hospital stay until Gram-negative bacteremia was 19±17 (range 3-82) days. Mortality rates at 14 days and at 30 days after the bacteremia were, respectively, 28.5% and 38.4%.
Univariate analysis revealed that the risk factors for mortality at day 14 included: Older age, higher APACHE II scores, intensive care unit stay, mechanical ventilation support, existence of arterial line and central venous catheter, urinary catheter, receiving total parenteral nutrition (TPN), hypotension, hypothermia, unconsciousness, elevated levels of urea (Table 1) . 
DISCUSSION
This study was undertaken to evaluate the risk factors for mortality in patients with Gram-negative bacteremia. In this study, the most frequently detected microorganisms were E.coli, Acinetobacter spp., P. aeruginosa, Klebsiella spp., Enterobacter spp. and S. maltophilia in rank order. We found that APACHE II score over 20, inappropriate antibiotic treatment, receiving TPN, unconsciousness and thrombocytopenia were significant independent risk factors for mortality at day 30 after the Gram-negative bacteremia. Inadequately treated patients had mortality rates significantly higher than adequately treated patients. The 30th day mortality rate was 38.4%, with rates of 32.3% and 78.8% for patients that received appropriate and inappropriate antimicrobial therapy, respectively. Furthermore, in 144 (60.0%) patients empirical antibiotic treatment was appropriate and 112 out of 144 (77.8%) patients survived whereas 60 out of 96 (62.5%) patients with inappropriate empirical therapy survived at day 14.
Bacteremia continues to be a major cause of morbidity and mortality in hospitals. Gram-negative bacilli are responsible for a considerable percentage of all nosocomial bacteremia. 12 The crude mortality associated with bloodstream infection approximates 35%, ranging from 12% to 80% and the attributable mortality due to nosocomial bloodstream infection averaged 26%. 13 In this study, we found an in-hospital crude mortality rate of 41.9%, 28.5% at 14 th day and 38.4% at 30th day in Gram negative bacteremia.
The outcomes of bloodstream infections depend on underlying conditions, the severity of illness and the suitability of antibiotics.
14 ICU patients represented 34% of all hospital Gram-negative bacteremias. 15 In this study, 43.8% of the patients were followed up at ICUs. Gram-negative bacteremia in the setting of critical illness, as determined by admission to ICU, has been associated with higher mortality rates and prolonged ICU stay. 16, 17 The mortality rate in a study of Gram-negative sepsis in five ICUs in Taipei was 36.1%, with 77.4% of all deaths directly related to the bloodstream infection. 18 Sligl et al. reported mortality rate for patients with nosocomial Gram-negative bacteremia as 53.3% in the ICU. 5 In this study, 30 day mortality rate in the ICUs was 59.5% whereas 21.8% in wards.
High APACHE II score have been reported as an independent risk factor in patients with bacteremia in several studies. [19] [20] [21] In this study high APACHE II score also was an independent risk factor for mortality.
It was reported that critically ill patients with primary bacteremia present significant mortality strongly associated with age. 22 In this study, 49.5% of the fatal cases and 35.3% of the survivors were over the age of 65 years.
There are several studies indicating that antibiotic resistant Gram-negative bacteremia were resulted in prolonged hospitalization and increased mortality. 7, [23] [24] [25] [26] However, there are studies showing no significant impact of antibiotic resistance on mortality. 27 FI GU RE 1: Kap lan-Me i er sur vi val es ti ma tes by su i ta bi lity of the tre at ment. The inap prop ri a te tre at ment gro up has the lo wer pro ba bi lity of sur vi val compa red to the ap prop ri a te the rapy gro up.
antibiotic resistant bacteremia were, respectively, 41.8% and 45.0%. 19 In this study, MDR in E. coli and Klebsiella spp. and imipenem resistance in Acinetobacter spp. and Pseudomonas spp. strains were not associated with increased risk of mortality. There were not any pan-resistant strains of Gram-negative bacteria in this study, therefore the patients had at least one antibiotic option for treatment.
Appropriate antimicrobial therapy has been shown to reduce mortality among patients with Gram-negative bacteremia and, when initiated early, to have a favorable effect on outcome in critically ill patients with bacteremia or other serious infections. 14, 29 Patients who received appropriate antimicrobial therapy throughout the course of infection had the lowest mortality. 30 Blood culture is the gold standard for the detection of bloodstream microbial pathogens. However, lack of rapidity is a major problem, identification of pathogen causing bacteremia requires 12 to 48 hours or more in the bacterial or fungal infection. 31 In addition, time loss caused by delay in reporting system further increases the amount of time spent in initiating appropriate treatment. In this study, antibiotic treatment was inappropriate in 33 (13%) patients due to negative characteristics of blood culture system described above. Mortality rate was 72.7% in patients receiving inappropriate antibiotic treatment and 22.3% in patients receiving appropriate antibiotic treatment at day 14 and 78.8% (26/33) and 32.3% (71/220) respectively at day 30. The use of molecular diagnostic methods that allow a faster identification of microorganisms in blood can be effective in preventing such losses. 32, 33 Inappropriate initial antimicrobial therapy, defined as an antimicrobial regimen that lacks in vitro activity against the isolated organism responsible for the infection, can lead to treatment failures and adverse patient outcomes. 34 Kumar et al. examined outcomes in 2,500 subjects with septic shock and concluded that each 1-hour delay in the administration of appropriate antibiotics was associated with a 10% increase in the probability of death. 35 Peralta et al. reported that adequacy of empirical antibiotic treatment is an independent risk factor for mortality in patients with E. coli bacteremia. 36 In this study, empirical antibiotics were given to 240 patients at the day of blood culture collection, and in 144 (60.0%) patients empirical antibiotic treatment was appropriate and 112 out of 144 (77.8%) patients survived whereas 60 out of 96 (62.5%) patients with inappropriate empirical therapy survived at day 14.
To conclude, awareness of mortality risk factors is important for the prognosis. Appropriate antibiotic treatment could decrease deaths associated with Gram-negative bacteremia.
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